Clinical Trial Update: Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating paclitaxel-binding albumin and cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Paclitaxel-binding albumin (paclitaxel-binding albumin)

Snippet

Sponsor: Third Military Medical University | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN